Trial site
Klinikum Nürnberg Nord
- 10running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Prostate cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- COPD1 trial
- Diffuse large B-cell lymphoma1 trial
- Liver cirrhosis1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Primary biliary cholangitis1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Recruiting4 trials
- Completed3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- Boston Scientific Corporation1 trial
- Bristol-Myers Squibb1 trial
- DKMS gemeinnützige GmbH1 trial
- EuMelaReg gGmbH1 trial
- and 6 more
Running trials
Not yet recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer
Active, not recruiting
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Recruiting
Active, not recruiting
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- COPD1 recruiting
- Liver cirrhosis1 recruiting
- Lung cancer1 recruiting
- Primary biliary cholangitis1 recruiting
Closed trials
Recruiting
Completed
BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma Patients
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026